Sama Therapeutics is a precision neuropsychiatry AI/ML platform that synthesizes and validates predictive biomarkers grounded in neural, physiological, multi-omics, natural language, and behavioral phenotypes. The company's agile SaaS platform, iMAGiNE™, analyzes the transdiagnostic efficacy of pharmaceutical and neurostimulation modalities through precision clinical trials, causal inference, preclinical translation, and generative AI trained on proprietary and open-science datasets. With an extraordinarily interdisciplinary team, Sama Therapeutics is advancing "software as medical device" for a range of indications, including cognitive, affective, interoceptive, and substance use disorders. We invite partners to join our mission unlocking brain health through integrative neurotechnology and proven “transprognostic” algorithms: https://brainclinics.com/tdbrain-challenge/

Please reach out to contact@sama.ac for more information and a live demo.

AI/ML

Life Sciences

Therapeutics

Sama Therapeutics

Sama Therapeutics' headquarters in Cambridge, United States

The Paris office focuses on advanced machine learning solutions, driving innovation in AI technology and development.

People (1)

Jobs (0)

Other offices